Fosalvudine tidoxil
Fosalvudine tidoxil is an orally active nucleoside reverse transcriptase inhibitor (NRTI). Fosalvudine tidoxil is a prodrug derived from Alovudine (HY-B1516). Fosalvudine tidoxil is less toxic than Alovudine and can be used for the research of HIV-1 infection.
For research use only. We do not sell to patients.
- CAS No.: 763903-67-9
- Formula: C35H64FN2O8PS
- Molecular Weight:722.93
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Nucleoside reverse transcriptase[1]
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley rats[1]
-
Dosage:15, 40, or 100 mg/kg/day
-
Administration:Oral gavage, 8 weeks
-
Result:Induced significant mtDNA depletion. At doses of 15, 40, and 100 mg/kg, the mean hepatic mtDNA values were 62, 64, and 47% of control values, respectively.
Chemical Information
-
CAS No. 763903-67-9
-
Molecular Weight 722.93
-
Formula C35H64FN2O8PS
-
SMILES
O=P(OC[C@H]1O[C@@H](N(C(N2)=O)C=C(C)C2=O)C[C@@H]1F)(OCC(OCCCCCCCCCC)CSCCCCCCCCCCCC)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)